Page last updated: 2024-08-21

butorphanol and Breast Neoplasms

butorphanol has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, W; Ji, X; Liu, X; Shan, S; Wang, L; Zhang, B	1

Trials

1 trial(s) available for butorphanol and Breast Neoplasms

Article	Year
Study of ultrasound-guided ropivacaine combined with butorphanol continuous paravertebral block to prevent pain syndrome by evaluating ccl2 gene expression after radical mastectomy. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Jan-02, Volume: 67, Issue:4 Topics: Breast Neoplasms; Butorphanol; Chemokine CCL2; Female; Gene Expression; Humans; Mastectomy; Mastectomy, Radical; Pain, Postoperative; Ropivacaine; Ultrasonography, Interventional	2022

Article

Year

Study of ultrasound-guided ropivacaine combined with butorphanol continuous paravertebral block to prevent pain syndrome by evaluating ccl2 gene expression after radical mastectomy.

Cellular and molecular biology (Noisy-le-Grand, France), 2022, Jan-02, Volume: 67, Issue:4

Topics: Breast Neoplasms; Butorphanol; Chemokine CCL2; Female; Gene Expression; Humans; Mastectomy; Mastectomy, Radical; Pain, Postoperative; Ropivacaine; Ultrasonography, Interventional

2022